InSite Vision
InSite Vision Reports Third Quarter 2009 Financial Results
Published in Anti-Infectives Week, November 23rd, 2009
"We completed the third quarter with a solid cash position and increased product revenues," said Louis Drapeau, InSite Vision's Chief Executive Officer. "AzaSite sales have been growing steadily through the efforts of our partner Inspire Pharmaceuticals, and beginning in the third quarter, our royalty rate on AzaSite increased by five percent to 25 percent. In addition, this year we have conserved fiscal resources, significantly reducing our costs as...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
Source: Anti-Infectives Week (2009-11-23)
More Articles from Anti-Infectives Week
- BioMed Central
Perceived parent-pressure causes excessive antibiotic prescription - Anti-Infectives
Researchers from University of Arizona report details of new studies and findings in the area of anti-infectives - Antimicrobials
New findings in antimicrobials described by J. Jain and co-researchers - Arthroplasty
Studies from Hospital for Special Surgery, Surgery Department yield new information about arthroplasty - Drug Resistance
Data on drug resistance published by researchers at Lund University - Drug Resistance
Investigators at Curtin University of Technology have published new data on drug resistance - More from this issue of Anti-Infectives Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
